Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with Acute Myeloid Leukemia with normal karyotype

With a GDP (Gross Domestic Product) of US$ 26,467 ( € 33,630) per capita in Germany in 2012, the base-case ICER of US$ 4,928 per survived month projected to US$ 59,136 per survived year is in between the simple GDP and the three times GDP per capita.

Source: Leukemia Research - September 18, 2017 Category: Hematology Authors: Laura H örster, Richard F. Schlenk, Michael Stadler, Maria Gabriel, Felicitas Thol, Jan Schildmann, Jochen Vollmann, Ursula Rochau, Gaby Sroczynski, Jürgen Wasem, Arnold Ganser, Matthias Port, Anja Neumann Tags: Research paper Source Type: research